TONIX PHARMACEUTICALS HOLDING CORP. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $6.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-11.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-05-11
- TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was $6.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-03-31 was -$11.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-03-31 was -$8.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-03-31 was -$44.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2017 was -$5.00K, a 150.00% decline from fiscal 2016.
- TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2016 was $10.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2015 was -$19.00K, a 733.33% decline from fiscal 2014.
- TONIX PHARMACEUTICALS HOLDING CORP. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2014 was $3.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 79 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 82 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6.00K 10-Q · filed 2026-05-11 | |||||
| 2025-03-31 | -$11.00K 10-Q · filed 2026-05-11 | |||||
| 2024-03-31 | -$8.00K 10-Q · filed 2025-05-12 | |||||
| 2023-03-31 | -$44.00K 10-Q · filed 2024-05-13 | |||||
| 2022-03-31 | -$26.00K 10-Q · filed 2023-05-08 | |||||
| 2021-03-31 | -$1.00K 10-Q · filed 2022-05-09 | |||||
| 2020-03-31 | -$14.00K 10-Q · filed 2021-05-10 | |||||
| 2019-03-31 | $2.00K 10-Q · filed 2020-05-12 | |||||
| 2018-03-31 | -$1.00K 10-Q · filed 2019-05-13 | -$3.00K derived: sum of 2 quarters · filed 2019-05-13 | -$4.00K derived: sum of 3 quarters · filed 2019-05-13 | -$5.00K derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2017-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$3.00K derived: sum of 2 quarters · filed 2018-03-09 | -$4.00K derived: sum of 3 quarters · filed 2018-03-09 | -$5.00K 10-K · filed 2018-03-09 | ||
| 2017-09-30 | -$1.00K 10-Q · filed 2017-11-06 | -$2.00K derived: sum of 2 quarters · filed 2017-11-06 | -$3.00K 10-Q · filed 2017-11-06 | -$21.00K derived: sum of 4 quarters · filed 2018-05-11 | ||
| 2017-06-30 | -$1.00K 10-Q · filed 2017-08-11 | -$2.00K 10-Q · filed 2017-08-11 | -$20.00K derived: sum of 3 quarters · filed 2018-05-11 | -$27.00K derived: sum of 4 quarters · filed 2018-05-11 | ||
| 2017-03-31 | -$1.00K 10-Q · filed 2018-05-11 | -$19.00K derived: sum of 2 quarters · filed 2018-05-11 | -$26.00K derived: sum of 3 quarters · filed 2018-05-11 | -$34.00K derived: sum of 4 quarters · filed 2018-05-11 | ||
| 2016-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$25.00K derived: sum of 2 quarters · filed 2018-03-09 | -$33.00K derived: sum of 3 quarters · filed 2018-03-09 | $10.00K 10-K · filed 2018-03-09 | ||
| 2016-09-30 | -$7.00K 10-Q · filed 2017-11-06 | -$15.00K derived: sum of 2 quarters · filed 2017-11-06 | $28.00K 10-Q · filed 2017-11-06 | -$6.00K derived: sum of 4 quarters · filed 2017-11-06 | ||
| 2016-06-30 | -$8.00K 10-Q · filed 2017-08-11 | $35.00K 10-Q · filed 2017-08-11 | $1.00K derived: sum of 3 quarters · filed 2017-08-11 | $12.00K derived: sum of 4 quarters · filed 2017-08-11 | ||
| 2016-03-31 | $43.00K 10-Q · filed 2017-05-12 | $9.00K derived: sum of 2 quarters · filed 2017-05-12 | $20.00K derived: sum of 3 quarters · filed 2017-05-12 | $21.00K derived: sum of 4 quarters · filed 2017-05-12 | ||
| 2015-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | -$23.00K derived: sum of 2 quarters · filed 2017-04-13 | -$22.00K derived: sum of 3 quarters · filed 2017-04-13 | -$19.00K 10-K · filed 2017-04-13 | ||
| 2015-09-30 | $11.00K 10-Q · filed 2016-11-10 | $12.00K derived: sum of 2 quarters · filed 2016-11-10 | $15.00K 10-Q · filed 2016-11-10 | $16.00K derived: sum of 4 quarters · filed 2016-11-10 | ||
| 2015-06-30 | $1.00K 10-Q · filed 2016-08-05 | $4.00K 10-Q · filed 2016-08-05 | $5.00K derived: sum of 3 quarters · filed 2016-08-05 | $4.00K derived: sum of 4 quarters · filed 2016-08-05 | ||
| 2015-03-31 | $3.00K 10-Q · filed 2016-05-06 | $4.00K derived: sum of 2 quarters · filed 2016-05-06 | $3.00K derived: sum of 3 quarters · filed 2016-05-06 | $6.00K derived: sum of 4 quarters · filed 2016-05-06 | ||
| 2014-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $0.00 derived: sum of 2 quarters · filed 2016-03-03 | $3.00K derived: sum of 3 quarters · filed 2016-03-03 | $3.00K 10-K · filed 2016-03-03 | ||
| 2014-09-30 | -$1.00K 10-Q · filed 2015-11-06 | $2.00K derived: sum of 2 quarters · filed 2015-11-06 | $2.00K 10-Q · filed 2015-11-06 | $3.00K derived: sum of 4 quarters · filed 2016-03-03 | ||
| 2014-06-30 | $3.00K 10-Q · filed 2015-08-07 | $5.00K 10-Q · filed 2015-08-07 | $4.00K derived: sum of 3 quarters · filed 2016-03-03 | $4.00K derived: sum of 4 quarters · filed 2016-03-03 | ||
| 2014-03-31 | $2.00K 10-Q · filed 2015-05-08 | $1.00K derived: sum of 2 quarters · filed 2016-03-03 | $1.00K derived: sum of 3 quarters · filed 2016-03-03 | $1.00K derived: sum of 4 quarters · filed 2016-03-03 | $1.00K 10-Q · filed 2014-05-13 | |
| 2013-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | -$1.00K derived: sum of 2 quarters · filed 2016-03-03 | -$1.00K derived: sum of 3 quarters · filed 2016-03-03 | -$1.00K 10-K · filed 2016-03-03 | -$1.00K 10-K · filed 2014-03-28 | |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $0.00 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-13 | |||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |